In fact, obesity enhances the glycolysis pathway in splenic Th1 and Th17 cells, and adiponectin inhibits glycolysis in both an AMPK-dependent and -independent manner, resulting in the amelioration of inflammation (62). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.